Asymmetrical Glyco-Engineering of Monoclonal Antibodies Provides Insights into α-Gal Immunogenicity
- DOI
- 10.64898/2025.12.15.694461
- Published
- 2025-12-17
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2025.12.15.694461,
title = {Asymmetrical Glyco-Engineering of Monoclonal Antibodies Provides Insights into α-Gal Immunogenicity},
author = {Gerlof P. Bosman and Anna Ehlers and Thomas Buckley and Justyna M. Dobruchowska and Javier Sastre Toraño and Arthur E. H. Bentlage and André C. Knulst and Gestur Vidarsson and Geert-Jan Boons},
year = {2025},
doi = {10.64898/2025.12.15.694461},
url = {https://doi.org/10.64898/2025.12.15.694461}
}RIS
TY - JOUR TI - Asymmetrical Glyco-Engineering of Monoclonal Antibodies Provides Insights into α-Gal Immunogenicity AU - Gerlof P. Bosman AU - Anna Ehlers AU - Thomas Buckley AU - Justyna M. Dobruchowska AU - Javier Sastre Toraño AU - Arthur E. H. Bentlage AU - André C. Knulst AU - Gestur Vidarsson AU - Geert-Jan Boons PY - 2025 DO - 10.64898/2025.12.15.694461 UR - https://doi.org/10.64898/2025.12.15.694461 ER -
APA
Bosman, G. P., Ehlers, A., Buckley, T., Dobruchowska, J. M., Toraño, J. S., Bentlage, A. E. H., Knulst, A. C., Vidarsson, G., & Boons, G. (2025). Asymmetrical Glyco-Engineering of Monoclonal Antibodies Provides Insights into α-Gal Immunogenicity. https://doi.org/10.64898/2025.12.15.694461
Source records
- crossref · retrieved 2026-11-07T20:23:30.999Z